Sign In
Buy ATAI
$4.53
-0.280 (-5.82%)
At Close: Jun 03, 2026
Atai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage Data
09:28am, Tuesday, 01'st Jul 2025
Atai Life Sciences ATAI and Beckley Psytech Limited jointly announced topline results from the eight-week, quadruple-masked, dose-finding core stage of the Phase 2b trial of a single dose of BPL-003 (
atai Life Sciences Announces $50 Million Private Placement Financing
06:05am, Tuesday, 01'st Jul 2025
Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1 Financi
NEW YORK, and AMSTERDAM and OXFORD, United Kingdom, July 01, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to deve
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?
10:41am, Wednesday, 25'th Jun 2025
Here is how atai Life Sciences N.V. (ATAI) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
atai Life Sciences backed by positive sector readthrough from Compass Phase 3 data, analysts say
01:33pm, Monday, 23'rd Jun 2025
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) remains a ‘Buy' for analysts at Jefferies, who continue to see significant upside ahead for the company following the release of new data from Compass Pathw
Psychedelics regain momentum in 2025 on political tailwinds, clinical wins
03:48pm, Thursday, 19'th Jun 2025
The psychedelics sector is experiencing a resurgence of optimism in 2025 driven by a more favorable federal government under President Donald Trump's administration, shifting state-level policies, and
FDA seen likely to grant emergency use authorizations for psychedelics, boosting sector stocks
11:59am, Wednesday, 18'th Jun 2025
The Food and Drug Administration (FDA) may soon issue emergency use authorizations for psychedelic substances like psilocybin, proponents of psychedelic therapy believe, amid a shit in attitude toward
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders
Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V.
01:06pm, Monday, 09'th Jun 2025
Does atai Life Sciences N.V. (ATAI) have what it takes to be a top stock pick for momentum investors?
Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?
10:46am, Monday, 09'th Jun 2025
Here is how atai Life Sciences N.V. (ATAI) and Novartis (NVS) have performed compared to their sector so far this year.
ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders
04:49pm, Tuesday, 03'rd Jun 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Atai Life Sciences N.V. (NASDAQ: ATAI) and Beckley Psytech Limited is fair to Atai shar
atai Life Sciences gains maximum exposure to key psychedelic asset with Beckley Psytech merger
03:29pm, Monday, 02'nd Jun 2025
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) stock is poised to move higher following its planned merger with Beckley Psytech, as the combined entity will provide investors with maximum exposure to a pro
Meta to roll out AI-powered ad creation by late 2025, says WSJ
10:54am, Monday, 02'nd Jun 2025
Meta Platforms Inc (NASDAQ:META, ETR:FB2A, SWX:FB) is planning to let brands fully create and target ads using its artificial intelligence tools by the end of 2025, according to a report in the Wall S
atai Life Sciences and Beckley Psytech to merge in all-share deal, stock pops
09:21am, Monday, 02'nd Jun 2025
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) shares soared before Monday's opening bell after it announced it has inked a definitive agreement to merge with Beckley Psytech, a private clinical-stage biop
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
06:00am, Monday, 02'nd Jun 2025
NEW YORK and BERLIN and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a missi
